Acrivon Therapeutics, Inc. (ACRV)

Acrivon Therapeutics Statistics

Total Valuation

ACRV has a market cap or net worth of $75.76 million. The enterprise value is -$19.56 million.

Market Cap	75.76M
Enterprise Value	-19.56M

Important Dates

The last earnings date was Wednesday, May 13, 2026, after market close.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

ACRV has 42.80 million shares outstanding. The number of shares has increased by 2.31% in one year.

Current Share Class	42.80M
Shares Outstanding	42.80M
Shares Change (YoY)	+2.31%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	6.09%
Owned by Institutions (%)	27.23%
Float	27.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.72
P/TBV Ratio	0.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.98, with a Debt / Equity ratio of 0.03.

Current Ratio	8.98
Quick Ratio	8.84
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -60.39% and return on invested capital (ROIC) is -39.32%.

Return on Equity (ROE)	-60.39%
Return on Assets (ROA)	-36.22%
Return on Invested Capital (ROIC)	-39.32%
Return on Capital Employed (ROCE)	-85.10%
Weighted Average Cost of Capital (WACC)	14.90%
Revenue Per Employee	n/a
Profits Per Employee	-$1.02M
Employee Count	76
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +55.26% in the last 52 weeks. The beta is 2.02, so ACRV's price volatility has been higher than the market average.

Beta (5Y)	2.02
52-Week Price Change	+55.26%
50-Day Moving Average	1.72
200-Day Moving Average	1.83
Relative Strength Index (RSI)	44.79
Average Volume (20 Days)	854,797

Short Selling Information

The latest short interest is 2.46 million, so 5.76% of the outstanding shares have been sold short.

Short Interest	2.46M
Short Previous Month	2.39M
Short % of Shares Out	5.76%
Short % of Float	8.81%
Short Ratio (days to cover)	3.05

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-82.35M
Pretax Income	-77.27M
Net Income	-77.27M
EBITDA	-80.93M
EBIT	-82.35M
Earnings Per Share (EPS)	-$2.00

Balance Sheet

The company has $97.74 million in cash and $2.42 million in debt, with a net cash position of $95.32 million or $2.23 per share.

Cash & Cash Equivalents	97.74M
Total Debt	2.42M
Net Cash	95.32M
Net Cash Per Share	$2.23
Equity (Book Value)	95.52M
Book Value Per Share	2.47
Working Capital	88.17M

Cash Flow

In the last 12 months, operating cash flow was -$64.67 million and capital expenditures -$1.63 million, giving a free cash flow of -$66.29 million.

Operating Cash Flow	-64.67M
Capital Expenditures	-1.63M
Depreciation & Amortization	1.43M
Net Borrowing	n/a
Free Cash Flow	-66.29M
FCF Per Share	-$1.55

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ACRV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.31%
Shareholder Yield	-2.31%
Earnings Yield	-101.99%
FCF Yield	-87.51%

Analyst Forecast

The average price target for ACRV is $11.50, which is 549.72% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.50
Price Target Difference	549.72%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1